Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2017

01-08-2017 | IM - COMMENTARY

Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes

Authors: Cecilia Becattini, Giancarlo Agnelli

Published in: Internal and Emergency Medicine | Issue 5/2017

Login to get access

Excerpt

The clinical presentation of pulmonary embolism is remarkably variable. The features of clinical presentation may be used to predict the short-term clinical outcome of patients with pulmonary embolism [1, 2]. Based on clinical presentation, patients’ features and presence/absence of right ventricle overload, at least three risk categories of patients with acute pulmonary embolism at expected low, intermediate or high risk for short-term death can be identified [3]. The final aim of risk stratification is to tailor treatment and patients’ management according to the expected risk for death [4]. …
Literature
1.
go back to reference Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389CrossRefPubMed Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389CrossRefPubMed
2.
go back to reference Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G (2012) Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res 130:847–852CrossRefPubMed Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G (2012) Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res 130:847–852CrossRefPubMed
3.
go back to reference Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, Vanni S, Nitti C, Kamphuisen P, Vedovati MC, De Natale MG, Konstantinides S (2016) Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 48:780–786CrossRefPubMed Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, Vanni S, Nitti C, Kamphuisen P, Vedovati MC, De Natale MG, Konstantinides S (2016) Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 48:780–786CrossRefPubMed
4.
go back to reference Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Authors/Task Force Members (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014(35):3033–3069 Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Authors/Task Force Members (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014(35):3033–3069
5.
go back to reference Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI (2017) External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. doi:10.1007/s11739-017-1625-9 PubMed Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI (2017) External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. doi:10.​1007/​s11739-017-1625-9 PubMed
6.
go back to reference Guercini F, Mommi V, Camporese G, Tonello C, Imberti D, Benedetti R, De Bartolomeo G, Di Lecce L, Romeo F, Agnelli G (2016) The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry. Intern Emerg Med 11:1095–1102CrossRefPubMed Guercini F, Mommi V, Camporese G, Tonello C, Imberti D, Benedetti R, De Bartolomeo G, Di Lecce L, Romeo F, Agnelli G (2016) The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry. Intern Emerg Med 11:1095–1102CrossRefPubMed
7.
go back to reference Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M (2016) Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open 6:e010324CrossRefPubMedPubMedCentral Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M (2016) Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open 6:e010324CrossRefPubMedPubMedCentral
8.
go back to reference Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046CrossRefPubMedPubMedCentral Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046CrossRefPubMedPubMedCentral
9.
go back to reference Jimenez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389CrossRefPubMed Jimenez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389CrossRefPubMed
10.
go back to reference Venetz C, Jiménez D, Mean M, Aujesky D (2011) A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 106:423–428CrossRefPubMed Venetz C, Jiménez D, Mean M, Aujesky D (2011) A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 106:423–428CrossRefPubMed
11.
go back to reference Polo Friz H, Molteni M, Del Sorbo D, Pasciuti L, Crippa M, Villa G, Meloni DF, Primitz L, Galli A, Rognoni M, Cavalieri d’Oro L, Arpaia G, Cimminiello C (2015) Mortality at 30 and 90 days in elderly patients with pulmonary embolism: a retrospective cohort study. Intern Emerg Med 10:431–436CrossRefPubMed Polo Friz H, Molteni M, Del Sorbo D, Pasciuti L, Crippa M, Villa G, Meloni DF, Primitz L, Galli A, Rognoni M, Cavalieri d’Oro L, Arpaia G, Cimminiello C (2015) Mortality at 30 and 90 days in elderly patients with pulmonary embolism: a retrospective cohort study. Intern Emerg Med 10:431–436CrossRefPubMed
12.
go back to reference Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N’gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41–48CrossRefPubMed Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N’gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41–48CrossRefPubMed
13.
go back to reference Maestre A, Trujillo-Santos J, Riera-Mestre A, Jiménez D, Di Micco P, Bascuñana J, Vela JR, Peris L, Malfante PC, Monreal M; RIETE Investigators (2015) Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy. Ann Am Thorac Soc 12:1122–1129 Maestre A, Trujillo-Santos J, Riera-Mestre A, Jiménez D, Di Micco P, Bascuñana J, Vela JR, Peris L, Malfante PC, Monreal M; RIETE Investigators (2015) Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy. Ann Am Thorac Soc 12:1122–1129
14.
go back to reference Zondag W, Mos IC, Creemers-Schild D, Hoogerbrugge AD, Dekkers OM, Dolsma J, Eijsvogel M, Faber LM, Hofstee HM, Hovens MM, Jonkers GJ, van Kralingen KW, Kruip MJ, de Vlasveld T, Vreede MJ, Huisman MV, Hestia Study Investigators (2011) Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 9:1500–1507CrossRefPubMed Zondag W, Mos IC, Creemers-Schild D, Hoogerbrugge AD, Dekkers OM, Dolsma J, Eijsvogel M, Faber LM, Hofstee HM, Hovens MM, Jonkers GJ, van Kralingen KW, Kruip MJ, de Vlasveld T, Vreede MJ, Huisman MV, Hestia Study Investigators (2011) Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 9:1500–1507CrossRefPubMed
15.
go back to reference den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvogel M, Faber LM, van Gerwen M, Grootenboers MJ, Heller-Baan R, Hovens MM, Jonkers GJ, van Kralingen KW, Melissant CF, Peltenburg H, Post JP, van de Ree MA, de Vlasveld LT, Vreede MJ, Huisman MV, Vesta Study Investigators (2016) Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial. Am J Respir Crit Care Med 194:998–1006CrossRef den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvogel M, Faber LM, van Gerwen M, Grootenboers MJ, Heller-Baan R, Hovens MM, Jonkers GJ, van Kralingen KW, Melissant CF, Peltenburg H, Post JP, van de Ree MA, de Vlasveld LT, Vreede MJ, Huisman MV, Vesta Study Investigators (2016) Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial. Am J Respir Crit Care Med 194:998–1006CrossRef
16.
go back to reference Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI (2016) External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thromb J 14:7CrossRefPubMedPubMedCentral Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI (2016) External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thromb J 14:7CrossRefPubMedPubMedCentral
17.
go back to reference Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT (2014) 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130:829–836CrossRefPubMed Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT (2014) 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130:829–836CrossRefPubMed
18.
go back to reference Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA (2009) Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 136:983–990CrossRefPubMed Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA (2009) Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 136:983–990CrossRefPubMed
19.
go back to reference Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W (2015) Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med 10:507–514CrossRefPubMed Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W (2015) Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med 10:507–514CrossRefPubMed
20.
go back to reference Becattini C, Agnelli G (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? No. Intern Emerg Med 10:281–284CrossRefPubMed Becattini C, Agnelli G (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? No. Intern Emerg Med 10:281–284CrossRefPubMed
21.
go back to reference Meyer G, Sanchez O, Planquette B (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? Yes. Intern Emerg Med 10:277–280CrossRefPubMed Meyer G, Sanchez O, Planquette B (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? Yes. Intern Emerg Med 10:277–280CrossRefPubMed
Metadata
Title
Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes
Authors
Cecilia Becattini
Giancarlo Agnelli
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 5/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1676-y

Other articles of this Issue 5/2017

Internal and Emergency Medicine 5/2017 Go to the issue